DAVID W OSBORNE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID W OSBORNE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID W OSBORNE. DAVID W OSBORNE is a Vice President - Dermatology in ATRIX LABORATORIES INC ($ATRX) and a VP Dermatology in ATRIX LABORATORIES INC ($ATRX) and a VP Dermatology in AGRICULTURAL EQUIPMENT CORP ($ATRX) and a Chief Technical Officer in Arcutis Biotherapeutics, Inc. ($ARQT).
Companies in which DAVID W OSBORNE is an Insider
AGRICULTURAL EQUIPMENT CORP
Industry:
Position of DAVID W OSBORNE: VP Dermatology
Holdings: 108,000 shares
Latest Transaction: Aug 07 2003
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Arcutis Biotherapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID W OSBORNE: Chief Technical Officer
Holdings: 246,753 shares
Latest Transaction: Mar 05 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ATRIX LABORATORIES INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID W OSBORNE: Vice President - Dermatology, VP Dermatology
Holdings: 5,647 shares
Latest Transaction: Aug 13 2003
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of DAVID W OSBORNE
Sentiment: All, ATRX, ARQT, ATRX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 05 2021 | ARQT | Arcutis Biotherape ... | OSBORNE DAVID W | Chief Technical Off ... | Option Exercise | A | 32.44 | 28,800 | 934,272 | 28,800 | |
| Mar 05 2021 | ARQT | Arcutis Biotherape ... | OSBORNE DAVID W | Chief Technical Off ... | Grant | A | 0.00 | 9,500 | 0 | 246,753 | 237.3 K to 246.8 K (+4.00 %) |
| Dec 16 2020 | ARQT | Arcutis Biotherape ... | OSBORNE DAVID W | Chief Technical Off ... | Sell | S | 30.00 | 15,000 | 450,000 | 250,533 | 265.5 K to 250.5 K (-5.65 %) |
| Oct 01 2020 | ARQT | Arcutis Biotherape ... | OSBORNE DAVID W | Chief Technical Off ... | Sell | S | 30.00 | 15,000 | 450,000 | 264,279 | 279.3 K to 264.3 K (-5.37 %) |
| Mar 03 2020 | ARQT | Arcutis Biotherape ... | OSBORNE DAVID W | Chief Technical Off ... | Option Exercise | A | 27.61 | 12,000 | 331,320 | 12,000 | |
| Mar 03 2020 | ARQT | Arcutis Biotherape ... | OSBORNE DAVID W | Chief Technical Off ... | Grant | A | 0.00 | 9,000 | 0 | 279,279 | 270.3 K to 279.3 K (+3.33 %) |
| Aug 13 2003 | ATRX | ATRIX LABORATORIES ... | OSBORNE DAVID W | Vice President - De ... | Option Exercise | M | 9.72 | 6,000 | 58,314 | 6,000 |